⌘K

Home/Filings/4/0000899243-22-008580

4//SEC Filing

Bachleda Mark 4

Accession 0000899243-22-008580

CIK 0001563577other

View on SEC.gov Company Profile

Filed

Mar 1, 7:00 PM ET

Accepted

Mar 2, 4:05 PM ET

Size

5.4 KB

Accession

0000899243-22-008580

Insider Transaction Report

Form 4

Period: 2022-02-28

Galera Therapeutics, Inc.GRTX

Chief Commercial Officer

Transactions

Award
Stock Option (Right to Buy)
2022-02-28+75,000→ 75,000 total
Exercise: $2.24Exp: 2032-02-27→ Common Stock (75,000 underlying)

Footnotes (1)

[F1]The option vests and becomes exercisable in 48 substantially equal monthly installments with the first installment vesting on March 28, 2022.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

Galera Therapeutics, Inc.

CIK 0001563577

Entity typeother

Related Parties

1

filerCIK 0001887762

Filing Metadata

Form type: 4
Filed: Mar 1, 7:00 PM ET
Accepted: Mar 2, 4:05 PM ET
Size: 5.4 KB

View on SEC.gov